Frontiers in New Drug Discovery : : From Molecular Targets to Preclinical Trials / / Dmitry Aminin.

The intention of this Special Issue is to focus on new aspects of drug discovery, including the search for new molecular targets of various diseases, the creation of new modern methods for diagnosing diseases, the development of new test systems and kits for assessing the selectivity and effectivene...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023.
Year of Publication:2023
Language:English
Physical Description:1 online resource (236 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993607577004498
ctrlnum (CKB)4960000000468839
(NjHacI)994960000000468839
(EXLCZ)994960000000468839
collection bib_alma
record_format marc
spelling Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials / Dmitry Aminin.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2023.
1 online resource (236 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
The intention of this Special Issue is to focus on new aspects of drug discovery, including the search for new molecular targets of various diseases, the creation of new modern methods for diagnosing diseases, the development of new test systems and kits for assessing the selectivity and effectiveness of new drugs, the study of the molecular mechanisms of biologically active compounds, the formulation of new drugs, pharmacokinetic and pharmacodynamic studies, and preclinical trials of important molecules.
Molecular theory.
Molecular structure.
3-0365-7682-7
Aminin, Dmitry, editor.
language English
format eBook
author2 Aminin, Dmitry,
author_facet Aminin, Dmitry,
author2_variant d a da
author2_role TeilnehmendeR
title Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials /
spellingShingle Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials /
title_sub From Molecular Targets to Preclinical Trials /
title_full Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials / Dmitry Aminin.
title_fullStr Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials / Dmitry Aminin.
title_full_unstemmed Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials / Dmitry Aminin.
title_auth Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials /
title_new Frontiers in New Drug Discovery :
title_sort frontiers in new drug discovery : from molecular targets to preclinical trials /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2023
physical 1 online resource (236 pages)
isbn 3-0365-7682-7
callnumber-first Q - Science
callnumber-subject QD - Chemistry
callnumber-label QD461
callnumber-sort QD 3461 F766 42023
illustrated Not Illustrated
dewey-hundreds 500 - Science
dewey-tens 540 - Chemistry
dewey-ones 541 - Physical chemistry
dewey-full 541.22
dewey-sort 3541.22
dewey-raw 541.22
dewey-search 541.22
work_keys_str_mv AT aminindmitry frontiersinnewdrugdiscoveryfrommoleculartargetstopreclinicaltrials
status_str n
ids_txt_mv (CKB)4960000000468839
(NjHacI)994960000000468839
(EXLCZ)994960000000468839
carrierType_str_mv cr
is_hierarchy_title Frontiers in New Drug Discovery : From Molecular Targets to Preclinical Trials /
author2_original_writing_str_mv noLinkedField
_version_ 1796653275504705536
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01480nam a2200289 i 4500</leader><controlfield tag="001">993607577004498</controlfield><controlfield tag="005">20230730125833.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230730s2023 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4960000000468839</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994960000000468839</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994960000000468839</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QD461</subfield><subfield code="b">.F766 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">541.22</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Frontiers in New Drug Discovery :</subfield><subfield code="b">From Molecular Targets to Preclinical Trials /</subfield><subfield code="c">Dmitry Aminin.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (236 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The intention of this Special Issue is to focus on new aspects of drug discovery, including the search for new molecular targets of various diseases, the creation of new modern methods for diagnosing diseases, the development of new test systems and kits for assessing the selectivity and effectiveness of new drugs, the study of the molecular mechanisms of biologically active compounds, the formulation of new drugs, pharmacokinetic and pharmacodynamic studies, and preclinical trials of important molecules.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Molecular theory.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Molecular structure.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-7682-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aminin, Dmitry,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-05 08:48:38 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-07-01 21:33:43 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5346552890004498&amp;Force_direct=true</subfield><subfield code="Z">5346552890004498</subfield><subfield code="b">Available</subfield><subfield code="8">5346552890004498</subfield></datafield></record></collection>